MiR-489 regulates chemoresistance in breast cancer via epithelial mesenchymal transition pathway

FEBS Letters

Volumn 588, Issue 11, 2014, Pages 2009-2015

  Jiang, Li ^a   He, Dongxu ^a   Yang, Dantong ^a   Chen, Zhen ^a   Pan, Qiongxi ^a   Mao, Aiqin ^a   Cai, Yanfei ^a   Li, Xiyuan ^a   Xing, Hui ^a   Shi, Mei ^a   Chen, Yun ^a   Bruce, Iain C ^a   Wang, Teng ^a   Jin, Linfang ^a   Qi, Xiaowei ^a   Hua, Dong ^a   Jin, Jian ^a   Ma, Xin ^a  

^a JIANGNAN UNIVERSITY   (China)

Author keywords

Breast cancer; Chemoresistance; Epithelial mesenchymal transition; microRNAs

Indexed keywords

DOXORUBICIN; MICRORNA; MICRORNA 489; SMAD3 PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER RESISTANCE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MCF 7 CELL LINE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REGULATORY MECHANISM; TUMOR XENOGRAFT;

BREAST CANCER; CHEMORESISTANCE; EPITHELIAL MESENCHYMAL TRANSITION; MICRORNAS;

3' UNTRANSLATED REGIONS; ANIMALS; ANTHRACYCLINES; ANTIBIOTICS, ANTINEOPLASTIC; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITORY CONCENTRATION 50; MCF-7 CELLS; MICE; MICE, NUDE; MICRORNAS; NEOADJUVANT THERAPY; RNA INTERFERENCE; SMAD3 PROTEIN; TAXOIDS; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84901009729     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2014.04.024     Document Type: Article

References (34)

1. D.B. Longley, and P.G. Johnston Molecular mechanisms of drug resistance J. Pathol. 205 2005 275 292
2. J. Gong, R. Jaiswal, J.M. Mathys, V. Combes, G.E. Grau, and M. Bebawy Microparticles and their emerging role in cancer multidrug resistance Cancer Treat. Rev. 38 2012 226 234
3. W. Jaeger Classical resistance mechanisms Int. J. Clin. Pharmacol. Ther. 47 2009 46 48
4. J.P. Thiery Epithelial-mesenchymal transitions in tumour progression Nat. Rev. Cancer 2 2002 442 454
5. J.P. Thiery, H. Acloque, R.Y. Huang, and M.A. Nieto Epithelial- mesenchymal transitions in development and disease Cell 139 2009 871 890
6. M. Iwatsuki, K. Mimori, T. Yokobori, H. Ishi, T. Beppu, S. Nakamori, H. Baba, and M. Mori Epithelial-mesenchymal transition in cancer development and its clinical significance Cancer Sci. 101 2010 293 299
7. D.S. Micalizzi, S.M. Farabaugh, and H.L. Ford Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression J. Mammary Gland Biol. Neoplasia 15 2010 117 134
8. L. Larue, and A. Bellacosa Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways Oncogene 24 2005 7443 7454
9. S. Thomson, E. Buck, F. Petti, G. Griffin, E. Brown, N. Ramnarine, K.K. Iwata, N. Gibson, and J.D. Haley Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition Cancer Res. 65 2005 9455 9462
10. M. Sabbah, S. Emami, G. Redeuilh, S. Julien, G. Prevost, A. Zimber, R. Ouelaa, M. Bracke, O. De Wever, and C. Gespach Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers Drug Resist. Updat. 11 2008 123 151
11. Y.N. Liu, J.J. Yin, W. Abou-Kheir, P.G. Hynes, O.M. Casey, L. Fang, M. Yi, R.M. Stephens, V. Seng, H. Sheppard-Tillman, P. Martin, and K. Kelly MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms Oncogene 32 2013 296 306
12. R. Kalluri, and R.A. Weinberg The basics of epithelial-mesenchymal transition J. Clin. Investig. 119 2009 1420 1428
13. J. Zhang, and L. Ma MicroRNA control of epithelial-mesenchymal transition and metastasis Cancer Metastasis Rev. 31 2012 653 662
14. H. Kajiyama, K. Shibata, M. Terauchi, M. Yamashita, K. Ino, A. Nawa, and F. Kikkawa Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells Int. J. Oncol. 31 2007 277 283
15. Z. Wang, Y. Li, A. Ahmad, A.S. Azmi, D. Kong, S. Banerjee, and F.H. Sarkar Targeting miRNAs involved in cancer stem cell and EMT regulation: an emerging concept in overcoming drug resistance Drug Resist. Updat. 13 2010 109 118
16. F.H. Sarkar, Y. Li, Z. Wang, D. Kong, and S. Ali Implication of microRNAs in drug resistance for designing novel cancer therapy Drug Resist. Updat. 13 2010 57 66
17. C.C. Pritchard, H.H. Cheng, and M. Tewari MicroRNA profiling: approaches and considerations Nat. Rev. Genet. 13 2012 358 369
18. J.L. Bryant, J. Britson, J.M. Balko, M. Willian, R. Timmons, A. Frolov, and E.P. Black A microRNA gene expression signature predicts response to erlotinib in epithelial cancer cell lines and targets EMT Br. J. Cancer 106 2012 148 156
19. X. Feng, Z. Wang, R. Fillmore, and Y. Xi MiR-200, a new star miRNA in human cancer Cancer Lett. 344 2013 166 173
20. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method Methods 25 2001 402 408
21. X. Ma, Y. Cai, D. He, C. Zou, P. Zhang, C.Y. Lo, Z. Xu, F.L. Chan, S. Yu, Y. Chen, R. Zhu, J. Lei, J. Jin, and X. Yao Transient receptor potential channel TRPC5 is essential for P-glycoprotein induction in drug-resistant cancer cells Proc. Natl. Acad. Sci. U.S.A. 109 2012 16282 16287
22. X. Ma, Z. Chen, D. Hua, D. He, L. Wang, P. Zhang, J. Wang, Y. Cai, C. Gao, X. Zhang, F. Zhang, T. Wang, T. Hong, L. Jin, X. Qi, S. Chen, X. Gu, D. Yang, Q. Pan, Y. Zhu, Y. Chen, D. Chen, L. Jiang, X. Han, Y. Zhang, J. Jin, and X. Yao Essential role for TrpC5-containing extracellular vesicles in breast cancer with chemotherapeutic resistance Proc. Natl. Acad. Sci. U.S.A. 111 2014 6389 6394
23. S.M. Ahn, J.Y. Cha, J. Kim, D. Kim, H.T. Trang, Y.M. Kim, Y.H. Cho, D. Park, and S. Hong Smad3 regulates E-cadherin via miRNA-200 pathway Oncogene 31 2012 3051 3059
24. U. Valcourt, M. Kowanetz, H. Niimi, C.H. Heldin, and A. Moustakas TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition Mol. Biol. Cell 16 2005 1987 2002
25. J. Chen, W. Tian, H. Cai, H. He, and Y. Deng Down-regulation of microRNA-200c is associated with drug resistance in human breast cancer Med. Oncol. 29 2012 2527 2534
26. D.R. Bell, J.H. Gerlach, N. Kartner, R.N. Buick, and V. Ling Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance J. Clin. Oncol. 3 1985 311 315
27. X.J. Li, M.H. Ji, S.L. Zhong, Q.B. Zha, J.J. Xu, J.H. Zhao, and J.H. Tang MicroRNA-34a modulates chemosensitivity of breast cancer cells to adriamycin by targeting Notch1 Arch. Med. Res. 43 2012 514 521
28. S. Saad, S.R. Stanners, R. Yong, O. Tang, and C.A. Pollock Notch mediated epithelial to mesenchymal transformation is associated with increased expression of the Snail transcription factor Int. J. Biochem. Cell Biol. 42 2010 1115 1122
29. N. Kikkawa, T. Hanazawa, L. Fujimura, N. Nohata, H. Suzuki, H. Chazono, D. Sakurai, S. Horiguchi, Y. Okamoto, and N. Seki MiR-489 is a tumour-suppressive miRNA target PTPN11 in hypopharyngeal squamous cell carcinoma (HSCC) Br. J. Cancer 103 2010 877 884
30. J. Dzwonek, O. Preobrazhenska, S. Cazzola, A. Conidi, A. Schellens, M. van Dinther, A. Stubbs, A. Klippel, D. Huylebroeck, P. ten Dijke, and K. Verschueren Smad3 is a key nonredundant mediator of transforming growth factor beta signaling in Nme mouse mammary epithelial cells Mol. Cancer Res. 7 2009 1342 1353
31. E.A. Kohn, Z. Du, M. Sato, C.M. Van Schyndle, M.A. Welsh, Y.A. Yang, C.H. Stuelten, B. Tang, W. Ju, E.P. Bottinger, and L.M. Wakefield A novel approach for the generation of genetically modified mammary epithelial cell cultures yields new insights into TGFbeta signaling in the mammary gland Breast Cancer Res. 12 2010 R83
32. T. Vincent, E.P. Neve, J.R. Johnson, A. Kukalev, F. Rojo, J. Albanell, K. Pietras, I. Virtanen, L. Philipson, P.L. Leopold, R.G. Crystal, A.G. de Herreros, A. Moustakas, R.F. Pettersson, and J. Fuxe A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition Nat. Cell Biol. 11 2009 943 950
33. H. Dang, W. Ding, D. Emerson, and C.B. Rountree Snail1 induces epithelial-to-mesenchymal transition and tumor initiating stem cell characteristics BMC Cancer 11 2011 396
34. M.G. Mendez, S. Kojima, and R.D. Goldman Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition FASEB J. 24 2010 1838 1851